Completed PHASE3 INTERVENTIONAL 1-arm NCT02321865

Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency

Sponsor: Nobelpharma

Interventions NPC-02

Updated 8 times since 2017 Last updated: Apr 14, 2019 Started: Jan 21, 2015 Primary completion: Nov 30, 2015 Completion: Nov 24, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Zinc Deficiency and is currently completed. Nobelpharma leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
May 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Jun 2018 — May 2019 [monthly]

Unknown Status PHASE3
Aug 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Aug 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nobelpharma

Data source: Nobelpharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Osaka, Japan